Anticancer, antioxidant, and antibacterial activity of chemically fingerprinted extract from Cyclamen persicum Mill.

In the last few decades, researchers have thoroughly studied the use of plants in Palestine, one of them is Cyclamen persicum Mill. (C. persicum). Cyclamen persicum has been historically cultivated since the 1700s due to its tuber. The tuber is known to stimulate the nasal receptors, thus triggering the sensory neurons. Cyclamen persicum has anti-inflammatory effects, reduces cholesterol levels, treats diabetes, and inhibits tumor growth. In this respect, in-vitro examination of antibacterial and anticancer activities and antioxidative potency of C. persicum ethanolic extract were evaluated. The antioxidative potency of the extracted plant material was determined spectrophotometrically using the DPPH free radical scavenging method and the HPLC-PDA method to evaluate its total phenolic content (TPC) and total flavonoid content (TFC). The experimental results revealed weak antibacterial activity of C. persicum extract against both gram negative (E. coli) and gram positive (Streptococcus aureus and S. aureus) bacterial strains, with the zones of inhibition found to be less than 8 mm. On the other hand, powerful activity against MCF7 breast cancer as well as HT29 colon cancer cell lines was obtained. The findings also revealed potent inhibition of free radicals and the presence of maximal levels of natural products such as phenolic compounds and flavonoids, which supportits biological activities and powerful ability to scavenge free radicals. HPLC results showed the presence of numerous flavonoid and phenolic compounds such as rutin, chlorogenic acid, kaempferol, trans-cinnamic acid, quercetin, sinapic acid, and p-coumaric acid.

Impact of Pretransplant Dialysis Modality on Posttransplant Outcomes: A Single-Center Experience.

OBJECTIVES: It remains unclear whether posttransplant outcomes differ according to the pretransplant dialysis modality (peritoneal dialysis vs hemodialysis). Our aim was to assess posttransplant outcomes in patients with different predialysis modalities. MATERIALS AND METHODS: Two thousand two hundred fifty-eight kidney recipients following up in Hamed Alessa Organ transplant center in Kuwait were included and divided into two groups according to pre-transplant dialysis modality: Group 1: those who received hemodialysis (HD) and group 2: those with peritoneal dialysis (PD). Demographics, pretransplant and posttransplant comorbidities, and patient and graft outcomes were studied. RESULTS: There were 1956 patients on hemodialysis, and 302 patients were on peritoneal dialysis. Most were male patients (1456 vs 802 female patients), with comparable mean age (P = .34). Chronic glomerulonephritis and diabetic nephropathy represented the most common original kidney disease before transplant (27.6% and 21.4%, respectively), with higher prevalence of glomerulonephritis in group 1 and diabetic nephropathy in group 2 (P = .001). The 2 groups were comparable with regard to immunosuppression (induction and maintenance) (P > .05). Posttransplant diabetes and hypertension were significantly higher in the hemodialysis group (P = .004 and P = 003, respectively). There was no significant difference between the 2 groups with regard to the graft outcome (P = .86). However, patient survival was significantly higher in the hemodialysis group (81.2% vs 64.4%). CONCLUSIONS: Compared with peritoneal dialysis, pretransplant hemodialysis is associated with better posttransplant patient survival despite no difference in the graft outcome. Diabetes-related complications could be attributed to such outcomes.

Sodium-glucose co-transporter 2 inhibitors & glucagon-like peptide-1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients.

INTRODUCTION: Cardiovascular and renal complications define the outcomes of diabetic kidney transplant recipients (KTRs). The new diabetes medications have changed the management of diabetes. However, transplant physicians are still reluctant to use sodium-glucose cotransporter 2 inhibitors (SGLT2i) and Glucagon-like peptide-1 receptor agonists (GLP-1RA) post kidney transplantation due to fear of drug related complications and lack of established guidelines. PATIENTS AND METHODS: We collected 1-year follow-up data from records of 98 diabetic KTRs on SGLT2I, 41 on GLP- 1RA and 70 on standard-of-care medicines. Patients were more than 3 months post-transplant with a minimum estimated glomerular filtration rate (eGFR) of 25 ml/min/1.73 m2 . Demographic data were similar except for a slightly lower HbA1c in the control group and higher albuminuria in SGLT2i group. RESULTS: HbA1c dropped significantly by .4% in both SGLT2i and GLP-1RA compared to .05% in the control group. A significant decrease in BMI by .32 in SGLT2i and .34 in GLP-1RA was observed compared to an increase by .015 in control group. A tendency for better eGFR in study groups was observed but was non-significant except for the SGLT2i group with an eGFR above 90 (p = .0135). The usual dip in eGFR was observed in the SGLT2i group at 1-3 months. Albuminuria was significantly reduced in both study groups. Adverse events were minimal with comparable safety in all groups. CONCLUSION: The use of SGLT2i and GLP-1RA appears to be effective and safe in diabetic KTRs with good outcomes. Randomized control trials are required to confirm these findings and establish guidelines.

Assessment of antioxidant, antimicrobial, and anticancer activities of Sisymbrium officinale plant extract.

The most efficient and safe source of medications is the natural and traditional medications which are produced from plants and herbs. In this study, Sisymbrium officinale (S. officinale) was tested to explore its total phenolic and flavonoids contents. Antioxidant, antimicrobial, and anticancer activities were assessed as well. S. officinale was bought from a local Palestinian market, air-dried, and extracted with 99% ethanol with the aid of ultrasonication. The extract was tested on three types of bacteria using well diffusion method. The anti-microbial testing included three different types of bacteria, two gram-positive bacteria, Streptococcus and Staphylococcus and E. coli as a gram-negative bacterium. Antioxidant activity of the plant extract was conducted using DPPH method, while total phenolic and flavonoids contents were performed using a well-known assay chemical method. Anticancer activity of the extract was conducted against two cancer cell lines (breast (MCF7) and colon (HCT116) cancer cell lines). Results showed that the extract is rich polyphenolic and flavonoids and has strong antioxidant activity reflected by inhibition of free radicals (DPPH) (193.7 ± 3.4). The plant extract showed also strong antimicrobial activity against both E. coli and Streptococcus bacteria with of inhibition of 10 and 14 mm respectively. The extract of this plant also showed anticancer activity (about 6%) against MCF7 (breast cancer cell line).

Vaccine Rollout and Shift in Public Sentiment: Twitter-Based Surveillance Study.

This study aims to find out the variation of Twitter users' sentiment before and after the COVID-19 vaccine rollout. We analyzed all COVID-19 related tweets posted on Twitter within two timeframes: September 2020 (T1) and March 2021 (T2). A total of 3 million tweets from over 132 thousand users were analyzed. We then categorized the users into two groups whose overall sentiment shifted positively or negatively from T1 to T2. Our analysis showed that 27% of users' sentiment shifted from T1 to T2 positively and the users were more confident about vaccine safety and efficacy. Users reported positive sentiments about travelling and the easing of lockdown measures. Also, 20.4% of the users' sentiment shifted negatively from T1 to T2. This group of Twitter users were more concerned about the adverse side effects of the vaccine, the pace of vaccine development as well as the emerging novel coronavirus variants. Interestingly, over half of the users' overall sentiment remained the same in both periods of T1 and T2, indicating indifference about vaccine rollout. We believe that our analysis will support the exploration of public reaction to COVID-19 vaccine rollout and assess policy makers' decision to combat the pandemic.

Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model

BackgroundThe ongoing pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a serious threat to global public health and imposes a severe burden on the entire human population. Faced with a virus that can mutate its structure while immunity is incapacitated, a need to develop a universal vaccine that can boost immunity to coronaviruses is highly needed. DesignFive formulations of two types (CRCx2 and CRCx3) of immune complexes with an immunogen adjuvant were evaluated in a mouse model as candidate SARS CoV-2 vaccines in a pretrial prior to clinical trials in humans. CRCx3 comprises 3 different formulas and CRCx2 comprises 2. Balb/c mice were vaccinated intraperitoneally on days 0/7 with a high or low dose of CRCx2 or on days 0/7/14 with a high, medium, or low dose of CRCx3 series, and their blood was sampled for serum antibody measurements. Mice were challenged with live virus after immunization with either vaccine to evaluate prophylaxis ability or treated with them after challenge to evaluate therapeutic ability on day 15. Immunological markers and histopathological studies as well as titration of neutralizing antibodies to the vaccines were evaluated and analyzed. ResultsCRCx 3 and CRCx 2 vaccine candidates induced elevated levels of positive neutralizing antibodies as well as a cellular immune response with safety, efficient productivity, and good genetic stability for vaccine manufacturing to provide protection against SARS-CoV-2 with relatively higher levels with the high dose CRCx2 candidate combination. ConclusionsHighly efficient protection and therapeutic effect against SARS-CoV-2 were obtained with a double-dose immunization schedule spaced at 7-day intervals using injections 0.25 of or 0.40 ml of CRCx2 vaccine formulations with a 25-mm needle. These results support further evaluation of CRCx in a clinical trial on humans.

Mono and dual hetero-structured M@poly-1,2 diaminoanthraquinone (M = Pt, Pd and Pt-Pd) catalysts for the electrooxidation of small organic fuels in alkaline medium.

Oxidation of some small organic fuels such as methanol (MeOH), ethanol (EtOH) and ethylene glycol (EG) was carried out in an alkaline medium using palladium (Pd)-platinum (Pt) nanoparticles/poly1,2-diaminoanthraquinone/glassy carbon (p1,2-DAAQ/GC) catalyst electrodes. Pd and Pt were incorporated into the p1,2-DAAQ/GC electrode using the cyclic voltammetry (CV) technique. The obtained Pd/p1,2-DAAQ/GC, Pt/p1,2-DAAQ/GC, Pt/Pd/p1,2-DAAQ/GC and Pd/Pt/p1,2-DAAQ/GC nanocatalyst electrodes were characterized by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX) and CV methods. Real active surface area (A real) achieved by carbon monoxide (CO) adsorption using differential electrochemical mass spectroscopy (DEMS) technique. The electrochemical activity was evaluated and normalized to A real per metal loading mass. The electrocatalytic oxidation of the small organic fuels at the prepared nanocatalyst electrodes was studied in 1.0 M NaOH solutions by CV and chronoamperometric (CA) techniques. Pt/Pd/p1,2-DAAQ/GC nanocatalyst electrode exhibited enhanced catalytic activity, better durability and higher tolerance to carbon monoxide generated in the oxidation reaction when compared with the other three studied nanocatalysts. The present investigation suggests that the studied nanocatalysts can be successfully applied in direct oxidation of small organic fuels, especially MeOH.

Simultaneous and selective electrochemical determination of hydroquinone, catechol and resorcinol at poly(1,5-diaminonaphthalene)/glassy carbon-modified electrode in different media.

The electrochemical behavior of phenolic isomers hydroquinone (HQ), catechol (CC) and resorcinol (RC) was examined in poly(1,5-diaminonaphthalene)/glassy carbon-modified electrode (P1,5-DAN/GC M.E.) by cyclic voltammetry (CV), square wave voltammetry (SWV) and chronoamperometry (CA) techniques in perchloric acid (HClO4) and phosphate buffer solution (PBS, pH 7.0). P1,5-DAN/GC M.E. was investigated for simultaneous determination of HQ, CC and RC in single, binary and ternary systems. Oxidation peak potentials were negatively shifted with increasing oxidation peak current for HQ, CC and RC at P1,5-DAN/GC M.E. compared with bare GC electrode. The obtained results illustrate that the former electrode exhibits better performance towards the three isomers in PBS rather than in HClO4 solution. The catalytic currents for different concentrations of HQ, CC and RC showed good relationship in the range of 0.1-100 µM for all analytes and low detection limits (LOD) of 0.034, 0.059 and 0.14 µM for them, respectively, in a ternary system in PBS at pH 7.0. This method has been practically applied for the detection of these isomers in tap water with acceptable results.

Anticancer Activity, Antioxidant Activity, and Phenolic and Flavonoids Content of Wild Tragopogon porrifolius Plant Extracts.

Tragopogon porrifolius, commonly referred to as white salsify, is an edible herb used in folk medicine to treat cancer. Samples of Tragopogon porrifolius plant grown wild in Palestine were extracted with different solvents: water, 80% ethanol, and 100% ethanol. The extracts were analyzed for their total phenolic content (TPC), total flavonoid content (TFC), and antioxidant activity (AA). Four different antioxidant assays were used to evaluate AA of the extracts: two measures the reducing power of the extracts (ferric reducing antioxidant power (FRAP) and cupric reducing antioxidant power (CUPRAC)), while two other assays measure the scavenging ability of the extracts (2,2-azino-di-(3-ethylbenzothialozine-sulphonic acid (ABTS)) and 2,2-diphenyl-1-picrylhydrazyl (DPPH)). Anticancer activity of the plant extracts were also tested on HOS and KHOS osteosarcoma cell lines. The results revealed that the polarity of the extraction solvent affects the TPC, TFC, and AA. It was found that both TPC and AA are highest for plant extracted with 80% ethanol, followed by water, and finally with 100% ethanol. TFC however was the highest in the following order: 80% ethanol > 100% ethanol > water. The plant extracts showed anticancer activities against KHOS cancer cell lines; they reduced total cell count and induced cell death in a drastic manner.

Study of the Effect of Route of Administration of Mesenchymal Stem Cells on Cisplatin-Induced Acute Kidney Injury in Sprague Dawley Rats

BACKGROUND AND OBJECTIVES: Mesenchymal stem cells (MSCs) have been shown to ameliorate cisplatin-induced acute kidney injury (AKI). The present study compares the efficacy of different routes of MSCs administration on kidney damage and regeneration after cisplatin-induced AKI. METHODS: A single intraperitoneal injection of cisplatin (5 mg/kg) was used to induce AKI in 160 rats. MSCs (5×106) were given by either intravenous, intra-arterial or kidney sub capsular injection one day after cisplatin injection. Suitable control groups were included. Rats were sacrificed at 4, 7, 11 and 30 days after cisplatin injection. Kidney function parameters, kidney tissue oxidative stress markers, and scoring for renal tissue injury, regeneration and chronicity were all determined. RESULTS: MSCs by any routes were able to ameliorate kidney function deterioration and renal tissue damage induced by cisplatin. The overall results of the three routes were equal. Differences between the different routes in one parameter were transient and inconsistent with other parameters. CONCLUSION: Changing the route of MSCs injection does not have a major influence on the outcome. Future evaluation should focus on differences between the routes of administration considering the long term safety.